Neonatal Seizure Registry - Developmental Functional EValuation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cerebral Palsy
- Epilepsy
- Hypoxic Ischemic Encephalopathy
- Intellectual Disability
- Intracranial Hemorrhages
- Neonatal Seizure
- Stroke
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 2 years and 8 years
- Gender
- Both males and females
Description
Neonatal seizures due to brain injury (acute symptomatic seizures) are associated with high risk of neurodevelopmental disability in infancy. Although prognosis in early childhood is a critical question for parents and providers, outcomes beyond infancy are largely unknown. Further, parents of infan...
Neonatal seizures due to brain injury (acute symptomatic seizures) are associated with high risk of neurodevelopmental disability in infancy. Although prognosis in early childhood is a critical question for parents and providers, outcomes beyond infancy are largely unknown. Further, parents of infants with neonatal seizures are at risk for mental health disorders, which can undermine their ability to care for a child with medical complexity and may contribute to impaired child development. The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants enrolled at one of nine sites across the USA. Participants will be evaluated using developmental questionnaires and in-person neurodevelopmental testing. Parent well-being will be assessed at each time point.
Tracking Information
- NCT #
- NCT04337697
- Collaborators
- University of Michigan
- Stanford University
- Duke University
- Boston Children's Hospital
- Children's National Research Institute
- Massachusetts General Hospital
- Children's Hospital of Philadelphia
- Children's Hospital Medical Center, Cincinnati
- National Institute of Neurological Disorders and Stroke (NINDS)
- Investigators
- Principal Investigator: Hannah C. Glass, MDCM, MAS University of California, San Francisco